Mechanism: Circadian rhythms drive NAD+ peaks via NAMPT, activating SIRT1 to silence LINE1 retrotransposons through H3K9 deacetylation. Readout: Readout: Misaligned feeding (rest phase) reduces NAD+ amplitude, decreases SIRT1 occupancy at LINE1 promoters by ~30%, and raises LINE1 ORF1p protein levels two-fold, accelerating aging phenotypes.
Hypothesis
We propose that the circadian clock suppresses LINE1 retrotransposon activity through a NAD+‑SIRT1 axis that is directly gated by feeding time. In this model, BMAL1‑CLOCK drives daily oscillations of NAD+ biosynthesis via NAMPT, producing peak NAD+ levels during the biological active phase. High NAD+ activates SIRT1, which deacetylates histone H3K9 at LINE1 promoters, reinforcing heterochromatin and blocking transcription. When food intake is shifted to the rest phase, NAD+ rhythms dampen, SIRT1 activity falls, LINE1 derepression rises, and genomic instability accelerates aging phenotypes.
Mechanistic Rationale
- BMAL1‑dependent NAD+ synthesis: BMAL1:CLOCK heterodimers transcriptionally activate NAMPT, the rate‑limiting enzyme in the NAD+ salvage pathway, creating a circadian NAD+ peak that aligns with the active period (1).
- SIRT1 recruitment to LINE1: SIRT1 deacetylates H3K9 and promotes HP1 binding, establishing a repressive chromatin state that has been shown to limit retrotransposon transcription in multiple cell types (5).
- Feeding‑time control of NAD+: Time‑restricted feeding that matches the active phase sustains NAD+ oscillations, whereas misaligned feeding flattens the NAD+ curve, reducing SIRT1 activity (6).
- Consequences of LINE1 activation: Increased LINE1 retrotransposition causes DNA damage, senescence‑associated secretory phenotype, and stem‑cell exhaustion, hallmarks that are exacerbated by circadian disruption (7).
Testable Predictions
- In wild‑type mice, hepatic NAD+ levels and SIRT1 binding to LINE1 promoters will peak during the dark (active) phase and trough during the light (rest) phase; this rhythm will be abolished in Bmal1‑liver KO mice.
- Shifting food access to the light phase will reduce hepatic NAD+ amplitude by >40 %, decrease SIRT1 occupancy at LINE1 sites by ~30 %, and raise LINE1 ORF1p protein levels two‑fold within two weeks.
- Pharmacological boosting of NAD+ (e.g., NR supplementation) administered at the onset of the rest phase will rescue SIRT1‑LINE1 repression and attenuate senescence markers in misaligned‑fed mice.
- CRISPRi‑mediated knockdown of NAMPT will mimic the effects of circadian misalignment on LINE1 activity, even when feeding is timed correctly.
Falsifiability
If LINE1 repression persists despite loss of circadian NAD+ rhythms (e.g., in NAMPT‑deficient cells supplemented with exogenous NAD+ that fails to restore SIRT1‑LINE1 binding), the proposed NAD+‑SIRT1 gate would be refuted. Conversely, if SIRT1 recruitment to LINE1 is uncoupled from NAD+ levels and remains rhythmic under constant NAD+ conditions, the model would need revision.
Comments
Sign in to comment.